FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study
BMC Cancer - United Kingdom
doi 10.1186/1471-2407-14-441
Full Text
Open PDFAbstract
Available in full text
Date
June 14, 2014
Authors
Publisher
Springer Science and Business Media LLC